scholarly journals Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance

2012 ◽  
Vol 33 (7) ◽  
pp. 1203-1214.e2 ◽  
Author(s):  
Michael Ewers ◽  
Cathal Walsh ◽  
John Q. Trojanowski ◽  
Leslie M. Shaw ◽  
Ronald C. Petersen ◽  
...  
2013 ◽  
Vol 6 (3) ◽  
pp. 43-50
Author(s):  
Clara Zancada-Menéndez ◽  
Patricia Sampedro-Piquero ◽  
Azucena Begega ◽  
Laudino López ◽  
Jorge Luis Arias

Mild cognitive impairment is understood as a cognitive deficit of insufficient severity to fulfil the criteria for Alzheimer’s disease. Many studies have attempted to identify which cognitive functions are most affected by this type of impairment and which is the most sensitive neuropsychological test for early detection. This study investigated sustained and selective attention, processing speed, and the inhibition process using a sample of people divided into three groups mild cognitive impairment, Alzheimer disease and cognitively healthy controls selected and grouped based on their scores in the Mini Mental State Examination and Cambridge Cognitive Examination-revised. Three tests from the Cambridge Neuropsychological Test Automated Battery (Motor Screening Task, Stop Signal Task and Reaction time) were used as well as the d2 attention test. The results show that that participants with mild cognitive impairment and Alzheimer disease showed lower levels of concentration compared with the cognitively healthy controls group in the d2 test and longer reaction times in the Cambridge Neuropsychological Test Automated Battery, although the differences were not marked in the latter test. The impairments in basic cognitive processes, such as reaction time and sustained attention, indicate the need to take these functions into account in the test protocols when discriminating between normal aging and early and preclinical dementia processes.


Sign in / Sign up

Export Citation Format

Share Document